Cvs Group Share Price (CVSG)

...from last year...

CVSG is one of the largest integrated veterinary services providers in UK with more than 480 surgeries in UK, Netherlands, and Ireland, four laboratories and seven pet crematoria. The company operates Animal Direct, which is an online store selling animal related products such as food, medicines etc. The company is focused on delivering quality clinical care based on industry-leading clinical training and implementation of innovative techniques across practices. The group has been following a hybrid path of both acquisitions and organic growth from development of their investments and personnel. CVSG has seen strong growth in both sales and EBITDA during the interim reports in December and the latest trading update on 20/07/2021. EBITDA is expected to be above H1 FY21 of 18.4% driven by strong trading momentum.

Competitors:
IVC Evidensia – a leading company in the sector with more than 10000 vets and nurses and 100s of UK practices. The company is also focused on high quality service.
Medivet LTD – a company providing 24/7 services in over 350 veterinary practices around the UK. The company offers wide range of services from routing to surgery.

Key risks: the company is looking for more acquisitions, while maintaining a high goodwill figure on their balance sheet.

Short analysis:

Cash nearly doubled in the 31/12/2020 interim report
Net debt is positive, meaning cash on 31/12/2020 did not cover total debt
CA/CL =  0.92
Cash ratio (interim 31/12/2020) = 0.35
Interest coverage = 5.1
P/S = 3.57
BV ps = 236
Operating profit (annual 2020) = £18.5 million (yoy growth of 21%)
Gross profit Margin = 40%...

...from WealthOracleAM

https://wealthoracle.co.uk/detailed-result-full/CVSG/7

CVS Group CEO, Richard Fairman, CFO, Robin Alfonso and COO, Ben Jacklin present the interim results for the period ended 31 December 2021.

Watch the video here: https://www.piworld.co.uk/company-videos/cvs-group-cvsg-interim-results-2022-march-2022/

Or listen to the podcast here: https://piworld.podbean.com/e/cvs-group-cvsg-interim-results-2022-march-2022/

CVS Group, CEO, Richard Fairman summarises the interim results for the period ended 31 December 2021.

Watch the video here: https://www.piworld.co.uk/company-videos/cvs-group-cvsg-2022-interim-results-overview-march-2022/

Or listen to the podcast here: https://piworld.podbean.com/e/cvs-group-cvsg-2022-interim-results-overview-march-2022/

More of the same please for H2.
Interesting to note they have opted not to fight the CMA….the CMA has imposed an arbitrary ceiling of 30% market share….these round numbers plucked out the air by regulators are often wrong but can take years to fight through the courts…..a bigger competitor can do that and the landscape will change again in a few years.

£15 in the next week